<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Joint Head and Neck Radiotherapy-MRI Development Cooperative</submitter><funding>NIDCR NIH HHS</funding><funding>NIBIB NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>065501</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10627232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To improve segmentation accuracy in head and neck cancer (HNC) radiotherapy treatment planning for the 1.5T hybrid magnetic resonance imaging/linear accelerator (MR-Linac), three-dimensional (3D), T2-weighted, fat-suppressed magnetic resonance imaging sequences were developed and optimized.&lt;h4>Approach&lt;/h4>After initial testing, spectral attenuated inversion recovery (SPAIR) was chosen as the fat suppression technique. Five candidate SPAIR sequences and a nonsuppressed, T2-weighted sequence were acquired for five HNC patients using a 1.5T MR-Linac. MR physicists identified persistent artifacts in two of the SPAIR sequences, so the remaining three SPAIR sequences were further analyzed. The gross primary tumor volume, metastatic lymph nodes, parotid glands, and pterygoid musc</pubmed_abstract><journal>Journal of medical imaging (Bellingham, Wash.)</journal><pubmed_title>Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of &lt;i>in vivo&lt;/i> site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer.</pubmed_title><pmcid>PMC10627232</pmcid><funding_grant_id>R01 CA218148</funding_grant_id><funding_grant_id>F31 DE029093</funding_grant_id><funding_grant_id>T32 CA261856</funding_grant_id><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>TL1 TR003169</funding_grant_id><funding_grant_id>R01 DE025248</funding_grant_id><funding_grant_id>R01 DE028290</funding_grant_id><funding_grant_id>R25 EB025787</funding_grant_id><funding_grant_id>F31 DE031502</funding_grant_id><pubmed_authors>McDonald BA</pubmed_authors><pubmed_authors>Dresner MA</pubmed_authors><pubmed_authors>Mohamed ASR</pubmed_authors><pubmed_authors>Ahmed S</pubmed_authors><pubmed_authors>Way A</pubmed_authors><pubmed_authors>Corrigan KL</pubmed_authors><pubmed_authors>Andring L</pubmed_authors><pubmed_authors>Joint Head and Neck Radiotherapy-MRI Development Cooperative</pubmed_authors><pubmed_authors>Pinnix C</pubmed_authors><pubmed_authors>Fuller CD</pubmed_authors><pubmed_authors>Salzillo TC</pubmed_authors><pubmed_authors>Wahid KA</pubmed_authors><pubmed_authors>He R</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Mulder S</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Manzar GS</pubmed_authors><pubmed_authors>Yoder A</pubmed_authors><pubmed_authors>Stafford RJ</pubmed_authors><pubmed_authors>Christodouleas J</pubmed_authors><pubmed_authors>Naser MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of &lt;i>in vivo&lt;/i> site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer.</name><description>&lt;h4>Purpose&lt;/h4>To improve segmentation accuracy in head and neck cancer (HNC) radiotherapy treatment planning for the 1.5T hybrid magnetic resonance imaging/linear accelerator (MR-Linac), three-dimensional (3D), T2-weighted, fat-suppressed magnetic resonance imaging sequences were developed and optimized.&lt;h4>Approach&lt;/h4>After initial testing, spectral attenuated inversion recovery (SPAIR) was chosen as the fat suppression technique. Five candidate SPAIR sequences and a nonsuppressed, T2-weighted sequence were acquired for five HNC patients using a 1.5T MR-Linac. MR physicists identified persistent artifacts in two of the SPAIR sequences, so the remaining three SPAIR sequences were further analyzed. The gross primary tumor volume, metastatic lymph nodes, parotid glands, and pterygoid musc</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-06-01T20:32:04.178Z</modification><creation>2025-04-04T11:43:13.849Z</creation></dates><accession>S-EPMC10627232</accession><cross_references><pubmed>37937259</pubmed><doi>10.1117/1.JMI.10.6.065501</doi></cross_references></HashMap>